Our macular degeneration funded research

Age-related macular degeneration (AMD) is the leading cause of blindness in the aged population in developed countries. There are two types of AMD: dry AMD (also called geographic atrophy, GA) and wet AMD (neovascularisation). Dry AMD accounts for over 80% of AMD incidence, and currently there is no treatment for it. 

At present, these conditions are incurable so more investment in research to identify potential treatments remains crucial.

Current research projects

Can Diet Help To Beat AMD? - Dr Arjuna Ratnayaka, University of Southampton

Seeking biomarkers to predict AMD - Professor Glen Jeffery, UCL

Targeting autophagy to treat AMD - Dr Jian Liu, University of Bristol

A new drug therapy for age-related macular degeneration - Dr Xinhua Shu at Glasgow Caledonian University

The link between protein coding gene SIGIRR and the onset of AMD - Dr Mei Chen, Queen's University Belfast.

Exploring red-light phototherapy to treat AMD - Dr Elinor Thompson, University of Greenwich

Stop the clock on sight loss

Every 6 minutes someone in the UK receives the devastating news that they are going blind. That’s 250 people a day. 

Your gift can help to find new sight-saving solutions. 

If you can, please donate today. Thank you.

PLEASE DONATE